WHO: Omicron Now Detected in 57 Countries, More Hospitalizations Expected

Jack Phillips
By Jack Phillips
December 8, 2021COVID-19
WHO: Omicron Now Detected in 57 Countries, More Hospitalizations Expected
Francois, a medical worker, administers a nasal swab to a patient at a coronavirus disease testing center in Noyal-Chatillon-sur-Seiche near Rennes, France, on Dec. 1, 2021. (Stephane Mahe/Reuters)

The World Health Organization (WHO), in its weekly epidemiological report, announced Wednesday that 57 nations have reported COVID-19 Omicron cases so far.

Although it’s not clear whether the Omicron variant can lead to more severe COVID-19 symptoms, the U.N. health organization again said Wednesday that more data is needed to assess the severity of the disease, or whether its mutations can breach vaccines or natural immunity.

“Even if the severity is equal or potentially even lower than for Delta variant, it is expected that hospitalizations will increase if more people become infected and that there will be a time lag between an increase in the incidence of cases and an increase in the incidence of deaths,” WHO said in its report.

According to WHO, the number of reported COVID-19 cases in South Africa doubled to Dec.5 to more than 62,000. Large increases in the virus have been reported in nearby Eswatini, Zimbabwe, Mozambique, Namibia, and Lesotho, the agency said.

COVID-19 is the illness caused by the CCP (Chinese Communist Party) virus.

“Preliminary analysis suggests that the mutations present in the Omicron variant may reduce the neutralizing activity of antibodies resulting in reduced protection from natural immunity,” WHO said, adding that it’s not clear yet whether “mutations present on the Omicron variant may result in reduced protection from vaccine-derived immunity and data on vaccine effectiveness, including the use of additional vaccination doses.”

It’s not clear whether any deaths have been associated with the Omicron variant anywhere in the world. The strain has been reported in at least 19 U.S. states.

It comes as South African scientists this week released a report saying the Omicron variant can partially evade the protection from two doses of Pfizer’s COVID-19 vaccine. They said that data shows the two-dose regimen “may not be sufficient to protect against infection with the Omicron variant.”

Pfizer’s CEO, Albert Bourla, appeared to counter the new findings by saying that a booster dose of the vaccine is needed as a bulwark against Omicron.

“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” Bourla said in a statement. “Ensuring as many people as possible are fully vaccinated with the first two-dose series and a booster remains the best course of action to prevent the spread of COVID-19.”

In November, when WHO named the variant, it drew controversy for its decision and rationale to skip over the Greek alphabet letter “Xi,” explaining that because Xi is a common Chinese surname, it didn’t want to name the variant as such so as to not offend anyone. However, critics accused the U.N. health body of trying to placate the CCP and leader Xi Jinping.

From The Epoch Times

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.